First Spring Sign: Chinese Vaccines Maker Gets $290m Funding
Boom For Sector Despite Uncertain Future
Executive Summary
With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.